Cargando…

Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria

Background: HemoTypeSC is a rapid, point-of-care testing (POCT) device for sickle cell disease (SCD) that traditionally uses the capillary blood from heel stick collected at the point of testing, a procedure that makes mass screening cumbersome and less cost-effective. Using dried blood spots (DBS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okeke, Chinwe O., Chianumba, Reuben I., Isa, Hezekiah, Asala, Samuel, Nnodu, Obiageli E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644131/ https://www.ncbi.nlm.nih.gov/pubmed/36386848 http://dx.doi.org/10.3389/fgene.2022.1013858

Ejemplares similares

HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges
por: Nnodu, Obiageli, et al.
Publicado: (2019)

Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria
por: Isa, Hezekiah Alkali, et al.
Publicado: (2022)

Feasibility Study of the “HemoTypeSC” Test for the Rapid Screening of Sickle Cell Disease in Côte D'Ivoire
por: Kakou Danho, Jeannette Bassimbié, et al.
Publicado: (2021)

Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study
por: Nnodu, Obiageli E, et al.
Publicado: (2020)

Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example
por: Nnodu, Obiageli, et al.
Publicado: (2022)

Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey
por: Okocha, Emmanuel Chide, et al.
Publicado: (2022)

HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes
por: Adegoke, Samuel Ademola, et al.
Publicado: (2022)

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria
por: Chianumba, Reuben Ikechukwu, et al.
Publicado: (2022)

Dépistage hospitalier de la drépanocytose en République Démocratique du Congo (RDC) par HemoTypeSC: cas de la ville de Kindu
por: Aimé, Abdala Kingwengwe, et al.
Publicado: (2022)

Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders
por: Isa, Hezekiah, et al.
Publicado: (2023)

A Multi-centre Survey of Acceptability of Newborn Screening for Sickle Cell Disease in Nigeria
por: Nnodu, Obiageli E, et al.
Publicado: (2018)

Effect of Sickle Cell Trait on Human Immunodeficiency Virus Type 1 Infection
por: Okpala, Iheanyi, et al.
Publicado: (2022)

Diagnostic Accuracy of HemotypeSC as a Point-of-Care Testing Device for Sickle Cell Disease: Findings from a Southwestern State in Nigeria and Implications for Patient Care in Resource-Poor Settings of sub-Saharan Africa
por: Olatunya, Oladele S., et al.
Publicado: (2021)

Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica
por: Paintsil, Vivian, et al.
Publicado: (2023)

S127: CONSORTIUM ON NEWBORN SCREENING IN AFRICA FOR SICKLE CELL DISEASE
por: Nnodu, O, et al.
Publicado: (2022)

Community based screening for sickle haemoglobin among pregnant women in Benue State, Nigeria: I-Care-to-Know, a Healthy Beginning Initiative
por: Ezenwosu, Osita U., et al.
Publicado: (2021)

Child mortality from sickle cell disease in Nigeria: a model-estimated, population-level analysis of data from the 2018 Demographic and Health Survey
por: Nnodu, Obiageli E, et al.
Publicado: (2021)

P-062: MATRIX COMPARISON OF HEMOTYPESC AND SICKLESCAN POINT-OF-CARE DIAGNOSTICS FOR EARLY DIAGNOSIS OF SICKLE CELL DISEASE IN RURAL SUB-SAHARAN AFRICA
por: C., JAJA, et al.
Publicado: (2022)

White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa
por: Hsu, Lewis, et al.
Publicado: (2018)

Agreement between dried blood spots and HemoCue in Tamil Nadu, India
por: Roshania, Reshma P., et al.
Publicado: (2021)

Hemo-dynamics
por: Zamir, Mair
Publicado: (2016)

Contribution of malaria and sickle cell disease to anaemia among children aged 6–59 months in Nigeria: a cross-sectional study using data from the 2018 Demographic and Health Survey
por: Chao, Dennis L, et al.
Publicado: (2022)

Urinary Schistosomiasis in Urban and Semi-Urban Communities in South-Eastern Nigeria
por: OKEKE, Ogochukwu Caroline, et al.
Publicado: (2013)

The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology
por: Green, Nancy S., et al.
Publicado: (2022)

Fine needle aspiration cytology of bone tumours- the experience from the National Orthopaedic and Lagos University Teaching Hospitals, Lagos, Nigeria
por: Nnodu, Obiageli E, et al.
Publicado: (2006)

Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability
por: Ryan, Nessa, et al.
Publicado: (2020)

Editorial: Building capacity for sickle cell disease research and healthcare
por: Nembaware, Victoria, et al.
Publicado: (2023)

Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients
por: Wonkam, Ambroise, et al.
Publicado: (2015)

Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania
por: Anie, Kofi A, et al.
Publicado: (2021)

Hemos perdido el reino
por: Campos, Marco Antonio, 1949-
Publicado: (1987)

Hemos perdido el sol /
por: Lera, Angel María de, 1912-
Publicado: (1966)

A Cross-Sectional Study of Ascaris lumbricoides Infection in a Rural Community in Ebonyi State, Nigeria: Prevalence and Risk Factors
por: CAROLINE OKEKE, Ogochukwu, et al.
Publicado: (2015)

P-005: COMPARISON OF SICKLE SCAN AND HEMOTYPE SC AS POINT-OF-CARE NEWBORN SCREENING DIAGNOSTICS FOR SICKLE CELL DISEASE IN LUANDA, ANGOLA
por: B., SANTOS, et al.
Publicado: (2022)

Caring for Africa’s sickle cell children: will we rise to the challenge?
por: Oron, Assaf P., et al.
Publicado: (2020)

Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary
por: Gyamfi, Joyce, et al.
Publicado: (2021)

Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium
por: Nnodu, Obiageli Eunice, et al.
Publicado: (2022)

Role of local town planning authorities in building collapse in Nigeria: evidence from Enugu metropolis
por: Okeke, Francis O., et al.
Publicado: (2020)

Evidence-based interventions implemented in low-and middle-income countries for sickle cell disease management: A systematic review of randomized controlled trials
por: Gyamfi, Joyce, et al.
Publicado: (2021)

Newborn screening in Nigeria: will incorporating congenital hypothyroidism with sickle cell disease improve neonatal screening programme?
por: Iroro, Enameguolo Yarhere, et al.
Publicado: (2019)

Applying the WHO ICD-MM classification system to maternal deaths in a tertiary hospital in Nigeria: A retrospective analysis from 2014–2018
por: Akaba, Godwin O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m9tssb500cb4e4fbl72d6o1832